Gemcitabine-loaded RGD modified liposome for ovarian cancer: preparation, characterization and pharmacodynamic studies

MLA

Tang,Zhongyuan, et al. “Gemcitabine-Loaded RGD Modified Liposome for Ovarian Cancer: Preparation, Characterization and Pharmacodynamic Studies.” Drug Design, Development and Therapy, Sept. 2019. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.dovemedicalp..54f4af4ca49148621cbabba048078310&authtype=sso&custid=ns315887.

APA

Tang,Zhongyuan, Feng,Weiwei, Yang,Yiqing, & Wang,Qun. (2019). Gemcitabine-loaded RGD modified liposome for ovarian cancer: preparation, characterization and pharmacodynamic studies. Drug Design, Development and Therapy.

Chicago

Tang,Zhongyuan, Feng,Weiwei, Yang,Yiqing, and Wang,Qun. 2019. “Gemcitabine-Loaded RGD Modified Liposome for Ovarian Cancer: Preparation, Characterization and Pharmacodynamic Studies.” Drug Design, Development and Therapy, September. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.dovemedicalp..54f4af4ca49148621cbabba048078310&authtype=sso&custid=ns315887.